Psilocybin Laws in Connecticut
Connecticut has active legislation to create a psilocybin therapeutic framework. The state has a history of progressive drug reform and is watching neighboring Massachusetts and New York closely.
Current Legal Status
Active Legislation
Psilocybin remains a controlled substance under Connecticut law. Bills to establish a therapeutic access program have been introduced and are moving through committee in 2025–2026.
Key Legislation
HB 6688 (2025) proposed a regulated psilocybin therapy pilot program — passed committee, awaiting floor vote. Connecticut legalized recreational cannabis in 2021, which has lowered political resistance to further reform. **2026:** Connecticut launched research-focused pilot programs explicitly framed around veteran mental health — a distinctive angle that has helped the legislation hold bipartisan support.
Clinical Trials
Yale University School of Medicine has conducted psilocybin research. Check ClinicalTrials.gov for Connecticut-area enrolling studies.
Advocacy Organizations
Connecticut Psychedelic Therapy Coalition, Healing Advocacy Fund.
Related Resources
See how Connecticut compares to neighboring states and find therapy options for residents: